Remedy for dependancy is out there. For assist, name the free and confidential remedy referral hotline (1-800-662-HELP), or go to

GREENSBORO, N.C. — Louise Vincent figures her group, the North Carolina Survivors Union, saves a minimum of 1,690 lives a yr.

The harm-reduction and syringe service program distributes the opioid overdose reversal treatment naloxone to individuals who use medication. Analysis suggests this approach is effective, since individuals who use medication are most likely to witness an overdose and administer naloxone.

The 1,690 quantity refers to what number of instances contributors in the Survivors Union reported utilizing the treatment between July 2020 and June 2021. However the true variety of lives saved may very well be greater: This system distributed practically 9,400 doses of naloxone throughout that point.

Now, as overdose deaths nationwide attain all-time highs, the Biden administration has made growing entry to naloxone a key a part of its overdose prevention strategy. It has allotted an unprecedented $30 million in federal funds for harm-reduction teams and introduced the creation of a model law that state legislatures can cross to enhance entry.

However Vincent and her friends say the administration has not addressed their best barrier to acquiring the lifesaving treatment: naloxone’s prescription-only standing.

“This designation is the root of all evil,” mentioned Nabarun Dasgupta, a scientist at the College of North Carolina’s faculty of public well being and co-founder of the Buyers Club, a collective of greater than 100 harm-reduction packages in the U.S.

The Meals and Drug Administration authorized naloxone as a prescription drug to deal with opioid overdose in 1971, when it was solely an injectable drug. That continues to be the most cost-effective kind and the one used most by harm-reduction teams, which have lengthy relied on a take care of Pfizer to purchase the treatment for lower than $5 a dose. Nonetheless, newer, nasal spray variations of naloxone — together with the brand-name drug Narcan, which has a reduced worth of about $38 a dose — can be found in lots of police stations, libraries and faculties.

All 50 states permit people to purchase naloxone at the pharmacy with out a prescription. States don’t have the authority to designate it as an over-the-counter treatment, however they’ve created workarounds — resembling a state well being official writing one prescription that can be utilized for each resident. However these workarounds don’t apply to organizations that buy naloxone in bulk from drugmakers. When a hospital, harm-reduction group or every other group orders naloxone from pharmaceutical firms, the firms are required to deal with naloxone the means the federal authorities sees it: as a prescription treatment, Dasgupta mentioned. In consequence, the firms impose a collection of necessities on patrons.

For instance, a company that orders naloxone should have a physician signal for the order, and that physician should be somebody who has not signed for one other group. The group should even have an tackle that isn’t a non-public residence to obtain shipments, a medical or pharmacy license and the capacity to adjust to laws for storing and shelling out the medication.

Hospitals and well being departments can simply fulfill these necessities. However they are often onerous for smaller, grassroots teams, a lot of that are led by volunteers and function out of makeshift residence or automotive workplaces, mentioned Eliza Wheeler and Maya Doe-Simkins, co-founders of the Buyers Club and co-authors of a paper with Dasgupta on this topic.

When these teams can’t order naloxone, the folks they serve can die, Wheeler and Doe-Simkins mentioned.

These shoppers gained’t essentially flip to pharmacies. Certainly, as overdose deaths surged in 2020, pharmacy gross sales of naloxone decreased. The price of the treatment, necessities to indicate ID, a concern of discrimination from pharmacists and an incapacity to find a pharmacy that stocks naloxone are all limitations, mentioned West Virginia College researcher Robin Pollini, who research naloxone distribution.

So harm-reduction teams are calling on the FDA to permit naloxone to be offered over-the-counter to allow them to order it extra simply and distribute it to the folks at the best danger of overdosing.

Although all 50 states permit people to purchase naloxone, typically recognized by the brand-name drug Narcan, organizations that order the treatment from drugmakers are topic to federal guidelines that designate the drug as prescription-only. The foundations make accessing the lifesaving treatment tough for these at excessive danger of overdosing. (Aneri Pattani/KHN) (Aneri Pattani/KHN)
From July 2020 to June 2021, the North Carolina Survivors Union distributed practically 9,400 doses of naloxone. However the drug’s prescription-only standing implies that harm-reduction organizations wrestle to entry sufficient of the treatment. (Aneri Pattani/KHN) (Aneri Pattani/KHN)

The product has lengthy been deemed protected and efficient for neighborhood use, harm-reduction teams say, even by the FDA. Different advocates have steered that the Division of Well being and Human Providers problem an order permitting producers to promote naloxone to organizations shopping for in bulk with out a prescriber’s signoff.

“Having extra naloxone on the avenue can solely do good. It may’t do hurt,” mentioned Thomas Stopka, an epidemiologist and substance use researcher at Tufts College Faculty of Medication. “We have to pull out all the stops and take into account a bunch of various avenues to handle this problem of provide.”

The priority was highlighted this yr when a producing drawback depleted Pfizer’s inventory of naloxone and the firm couldn’t fill orders for harm-reduction teams. Hikma, one other firm that makes naloxone, provided to donate 50,000 injectable doses to the affected teams. However due to naloxone’s prescription standing and Hikma’s related paperwork necessities, solely three harm-reduction packages certified, Dasgupta mentioned. (Pfizer mentioned that the manufacturing problem has been resolved and that shipments resumed this fall.)

In Oklahoma, Cease Hurt on Tulsa Streets (SHOTS) didn’t qualify for Hikma’s donation as a result of the group didn’t have a physician who may signal for its order, co-founder Hana Fields mentioned. The physician the group had beforehand labored with retired in January, and SHOTS had but to discover a substitute. Many docs are apprehensive about legal responsibility or just don’t return her calls, she mentioned. In the meantime, SHOTS depends on naloxone donations from different packages.

“The stakes are so excessive. My mates are dying,” mentioned Fields, whose life has been saved by naloxone and who has been in restoration for seven years.

In a press release to KHN, the FDA laid accountability on the firms making naloxone, saying it has inspired pharmaceutical producers to use for over-the-counter designation for years, even doing the legwork to develop consumer-friendly labels which are sometimes the purview of firms.

“We proceed to hope that a number of sponsors will submit an software, as this might be the most direct regulatory path for the FDA to have the ability to approve a non-prescription naloxone,” the company mentioned.

However when, or if, that’ll occur is unclear.

Hana Fields is the co-founder of Cease Hurt on Tulsa Streets (SHOTS), a harm-reduction group in Oklahoma. Since the group’s physician retired in January, SHOTS has relied on naloxone donations from different packages throughout the state and nation. (Rosa Hernandez)

Pfizer and Hikma instructed KHN that they don’t have present plans to pursue an over-the-counter designation. Emergent BioSolutions, which makes Narcan, mentioned it’s “evaluating the potential for OTC naloxone” however warned of “unintended penalties” from the change, resembling insurers not masking the value and shoppers having to pay out-of-pocket. (Specialists say merchandise sometimes are cheaper when offered over the counter.)

Hurt Discount Therapeutics, a nonprofit pharmaceutical firm, mentioned it plans to use for an over-the-counter naloxone nasal spray subsequent yr, with the objective that or not it’s on cabinets in 2023. CEO Michael Hufford mentioned the firm will donate most of its product to harm-reduction teams and lift funds to offset the value to shoppers at retail pharmacies. At the moment, the bulk of the firm’s funding comes from Purdue Pharma, the maker of OxyContin.

However advocates say the FDA ought to make the change itself.

“We have now this lifesaving device accessible all through the complete time of this disaster, and the federal authorities has simply been sitting on its arms,” mentioned Leo Beletsky, a professor of regulation and well being sciences at Northeastern College in Boston.

Some pharmaceutical firms in the previous have argued that the authorities doesn’t have the authority to designate a prescription drug as over-the-counter, however others level to a statute that enables a drug’s prescription standing to be eliminated “when such necessities aren’t mandatory for the safety of the public well being.” In 1982, the FDA designated an asthma inhaler as an over-the-counter drug with out the firm’s request, although it later rescinded that standing due to widespread criticism that the inhalers could be overused.

In the meantime, harm-reduction organizations, like the North Carolina Survivors Union in Greensboro, see the demand for naloxone each day. Vincent, who runs the program, mentioned value and regulatory burdens forestall her from ordering naloxone instantly. As an alternative, she depends on donations from different teams. However she fears the day her group doesn’t have sufficient.

“I can’t look somebody in the eye and inform them I can’t give them drugs that’s going to avoid wasting their lives,” Vincent mentioned.

Aneri Pattani: [email protected], @aneripattani